Lab Medicine Significance 5/10

Hospital at Home Programs Expose Gaps in Decentralized Laboratory Support

This review examines the growing Hospital at Home model in Canada and highlights how clinical laboratories remain underserved despite their critical role across preanalytical, analytical, and post-analytical phases. The authors argue that successful decentralized inpatient care depends on integrating new testing technologies, including point-of-care devices, into home-based workflows. Addressing logistical barriers for lab involvement is essential to scaling these programs safely.

The original study

Hospital at Home programs: Decentralized inpatient care but centralized laboratory testing?

Authors
Shi J, Yu-Wei Chen R, Wang L
Journal
Clinical biochemistry
Type
Journal Article, Review
PMID
38871043
Read the original study →

Original abstract

The Hospital at Home (HaH) program has experienced accelerated growth in major Canadian provinces, driven in part by technological advancements and evolving patient needs during the COVID-19 pandemic. As an increasing number of hospitals pilot or implement these innovative programs, substantial resources have been allocated to support clinical teams. However, it is crucial to note that the vital roles played by clinical laboratories remain insufficiently acknowledged. This mini review aims to shed light on the diverse functions of clinical laboratories, spanning the preanalytical, analytical, and post-analytical phases within the HaH program context. Additionally, the review will explore recent advancements in clinical testing and the potential benefits of integrating new technologies into the HaH framework. Emphasizing the integral role of clinical laboratories, the discussion will address the current barriers hindering their active involvement, accompanied by proposed solutions. The capacity and efficiency of the HaH program hinge on sustained collaborative efforts from various teams, with clinical laboratories as crucial team players. Recognizing and addressing the specific challenges faced by clinical laboratories is essential for optimizing the overall performance and impact of the HaH initiative.